Diabetic Gastroparesis Treatment Market

Diabetic Gastroparesis Treatment Market, By Product Type (Drugs (Gastroprokinetic Agents, Antiemetic Agents, Botulinum Toxin), Surgical Treatment Products (Gastric Electrical Stimulation (GES) Device, Percutaneous Endoscopic Gastrostomy (PEG) Kit, Parenteral Nutrition)), By Disease Indication (Compensated Gastroparesis, Gastric Failure), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030


Gastroparesis is the delaying of gastric emptying without any evidence of mechanical obstruction. Diabetic gastroparesis is a potential complication that occurs in the setting of poorly controlled diabetes, resulting from dysfunction in the coordination and function of the autonomic nervous system, neurons, and specialized pacemaker cells of the stomach and intestine, and the smooth muscle cells of the gastrointestinal tract. Diabetic gastroparesis occurs as a result of dysfunction in the autonomic and enteric nervous systems. Chronically high levels of blood glucose (or inefficient glucose uptake) lead to neuronal damage resulting in abnormal myenteric neurotransmission, impaired inhibitory neuronal function, and dysfunctional smooth muscle and pacemaker cells of stomach.

Altogether, this dysfunction results in a combination of fewer contractions of the antrum, uncoordinated antro-duodenal contractions, and pyloric spasms, ultimately resulting in delayed gastric emptying (gastroparesis). Delayed gastric emptying in patients with diabetes, particularly of solids, may also occur in the setting of abnormal small bowel motility, which is thought to occur by a similar mechanism as that which is described in the stomach. Some patients with diabetes may additionally experience changes in gastric compliance, both increased or decreased, which may also contribute to delayed gastric emptying.

Market Dynamics

Increasing prevalence of diabetes worldwide, increasing geriatric population and sedentary lifestyle, increasing affordability and accessibility of medication to patients, and research and development activities on diabetic gastroparesis attributed to the growth of global diabetic gastroparesis treatment market. For instance, on June 23, 2020, Evoke Pharma, a U.S.-based pharmaceutical company, announced that the U.S. Food And Drug Administration has approved the new drug application for Gimoti nasal spray to relieve symptoms in adults with acute and recurrent diabetic gastroparesis. The drug, Metoclopramide has limited use due to associated side effects. Hence, a novel approach by introducing drug in trans nasal pathway is taken.

Key features of the study:

This report provides an in-depth analysis of the Global Diabetic Gastroparesis Treatment Market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global diabetic gastroparesis market based on the following parameters–Company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Janssen Global Services, LLC, Cardinal Health, Inc., Evoke Pharma, Inc., Salix Pharmaceuticals, Inc., Alfa Wassermann SPA, Abbott Laboratories, Medtronic Plc., C. R. Bard, Inc. (Becton, Dickinson and Company), Rhythm Pharmaceuticals, Inc., Boston Scientific Corporation, Kimberly-Clark Corporation, Vanda Pharmaceuticals, Inc., and Allergan, plc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global diabetic gastroparesis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diabetic gastroparesis treatment market

Detailed Segmentation:

Global Diabetic Gastroparesis Treatment Market, By Product Type:

Drugs

Gastroprokinetic Agents

Antiemetic Agents

Botulinum Toxin

Surgical Treatment Products

Gastric Electrical Stimulation (GES) Device

Percutaneous Endoscopic Gastrostomy (PEG) Kit

Parenteral Nutrition

Global Diabetic Gastroparesis Treatment Market, By Disease Indication:

Compensated Gastroparesis

Gastric Failure

Global Diabetic Gastroparesis Treatment Market, By Distribution channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Global Diabetic Gastroparesis Treatment Market, By Region:

North America

By Country:

U.S.

Canada

Latin America

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

Europe

By Country:

Germany

U.K.

France

Italy

Spain

Russia

Rest of Europe

Asia Pacific

By Country

China

India

Japan

Australia

South Korea

ASEAN

Rest of Asia Pacific

Middle East

By Country:

GCC

Israel

Rest of Middle East

Africa

By Country/Region:

South Africa

Central Africa

North Africa

Company Profiles

Janssen Global Services *

Company Highlights

Products Portfolio

Key Highlights

Financial Performance

Strategies

LLC, Cardinal Health, Inc.

Evoke Pharma, Inc.

Salix Pharmaceuticals, Inc.

Alfa Wassermann SPA

Abbott Laboratories

Medtronic Plc.,

C.R. Bard, Inc. (Becton, Dickinson and Company)

Rhythm Pharmaceuticals, Inc.

Boston Scientific Corporation

Kimberly-Clark Corporation

Vanda Pharmaceuticals, Inc.

Allergan, plc.

“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Product Type
Market Snapshot, By Disease Indication
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
4. Global Diabetic Gastroparesis Treatment Market- Impact of Coronavirus (Covid-19) Pandemic
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Diabetic Gastroparesis Treatment Market, By Product Type, 2018 – 2030, (US$ Million)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018–2030
Segment Trends
Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Segment Trends
Gastroprokinetic Agents
Antiemetic Agents
Botulinum Toxin
Surgical Treatment Products
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Segment trends
Gastric Electrical Stimulation (GES) Device
Percutaneous Endoscopic Gastrostomy (PEG) Kit
Parenteral Nutrition
6. Global Diabetic Gastroparesis Treatment Market, By Disease Indication, 2018 – 2030, (US$ Million)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018–2030
Segment Trends
Compensated Gastroparesis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Gastric Failure
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
7. Global Diabetic Gastroparesis Treatment Market, By Distribution channel, 2018 – 2030, (US$ Million)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018–2030
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
8. Global Diabetic Gastroparesis Treatment Market, By Region, 2018 – 2030, (US$ Million)
Introduction
Market Share Analysis, By Region, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Regions, 2018–2030
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product type, 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Million)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product type, 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product type, 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product type, 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product type, 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product type, 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018– 2030, (US$ Million)
North Africa
Central Africa
South Africa
9. Competitive Landscape
Janssen Global Services, LLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Cardinal Health, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Evoke Pharma, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Salix Pharmaceuticals, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Alfa Wassermann SPA
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Abbott Laboratories
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Medtronic Plc
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
C.R. Bard, Inc. (Becton, Dickinson and Company)
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Rhythm Pharmaceuticals, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Boston Scientific Corporation
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Kimberly-Clark Corporation.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Vanda Pharmaceuticals, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Allergan, plc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
10. Section
Research Methodology
About Us
*Browse 34 market data tables and 32 figures on “Diabetic Gastroparesis Treatment Market” - Global forecast to 2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings